Publication | Closed Access

Glutamic acid decarboxylase and ICA512/IA-2 autoantibodies as disease markers and relationship to residual β-cell function and glycemic control in young type 1 diabetic patients

Metabolic Syndromeβ-Cell FunctionDiabetes ManagementAutoimmune DiseaseMedicineDiabetesImmunologyAutoimmunityAutoantibodiesYoung Type 1Diabetes MellitusDisease MarkersGlycemic Response